(A) Immunoblot for the indicated proteins using lysates from livers taken from WT mice that were injected with vehicle (normal saline) or Epi (0.3 μg/g) for 10 min (n = 4).
(B) Immunoblot for the indicated proteins using lysates from livers taken from WT and β1/β2 double-knockout mice (Adrb1/2 DKO) treated with vehicle (V; saline) or Epi (E) via i.p. injection for 10 min.
(C) Immunoblot for the indicated proteins using lysates from liver taken from WT mice that were fasted for 18 h (Fasted) or fasted and then exposed for food for 4 h (Fed) (n = 5).
(D) Quantification of the ratios of pT1061 to total p110α, pAKT2 to total AKT2, and pAKT1 to total AKT1 using band intensity from (C). N = 5. Comparisons made via ANOVA with Dunnett’s post-test.
(E) Immunoblot for the indicated proteins using lysates from WT mouse primary hepatocytes exposed to vehicle (DMSO), insulin (Ins.; 100 nM), or insulin plus Fsk for the indicated times.
(F) Quantification of the ratios of pT1061 to total p110α and pAKT to total AKT using band intensity from (E). N = 3. Comparisons made via ANOVA with Dunnett’s post-test comparing to insulin group.
(G) Immunoblot for the indicated proteins using lysates from mouse primary hepatocytes isolated from Pik3caT1061A/T1061A mice (T1061 AA, N = 3) or WT littermates (T1061 TT, N = 1) exposed to insulin and Fsk for the indicated times.
(H) Quantification of the ratios of pT1061 to total p110α and pAKT to total AKT using band intensity from (G). N = 3. Data are presented as mean ± SEM. Comparisons made via ANOVA with Dunnett’s post-test comparing to insulin group.